(VXZ) iPath Series SP500 VIX - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US06746P6135

ETN, Futures Contracts, Mid-Term Futures, Volatility Index, Exposure

Description: VXZ iPath Series SP500 VIX

The iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) is designed to give investors exposure to the mid-term futures contracts on the CBOE Volatility Index (VIX), allowing them to capitalize on the volatility of the S&P 500 index. By investing in VXZ, investors are essentially taking a position on the markets expectation of future volatility, as reflected in the prices of VIX futures contracts with maturities between 4-7 months.

To understand the ETNs behavior, its essential to recognize that its tied to the performance of VIX futures contracts, not the VIX index itself. This distinction is crucial because the futures contracts can diverge from the spot VIX index due to factors like contango and backwardation. As a result, VXZs price movements may not perfectly mirror the VIX index, and investors should be aware of this discrepancy when using VXZ as a volatility proxy.

Analyzing the , we observe that VXZ is currently trading below its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a short-term downtrend. However, its still above its 200-day simple moving average (SMA200), suggesting a longer-term uptrend. The Average True Range (ATR) is 2.33, representing 4.09% of the current price, which implies moderate volatility. Given the current price of 56.79, and considering the 52-week high and low range (67.71 and 47.79, respectively), we can anticipate that VXZ will likely continue to fluctuate within this range.

Combining the insights from and , we can forecast that VXZ will likely experience a moderate increase in the short term, driven by the ongoing demand for volatility exposure. The relatively low AUM of 38.06M USD may lead to increased volatility, as smaller funds can be more susceptible to significant price movements. If the market continues to experience heightened volatility, VXZ may benefit from the increased demand for mid-term VIX futures contracts, potentially driving the price towards the 52-week high. However, if the market stabilizes, VXZ may face downward pressure, potentially trading towards the 52-week low.

Based on this analysis, a potential trading strategy could involve buying VXZ on dips towards the 52-week low, targeting a price around 60-62, with a stop-loss below 47.79. Conversely, if VXZ breaks above the 52-week high, it may be a sign of increased volatility, and a long position could be considered, targeting a higher price level.

VXZ ETF Overview

Market Cap in USD 37m
Category Trading--Miscellaneous
TER 0.89%
IPO / Inception 2018-01-17

VXZ ETF Ratings

Growth Rating -23.7%
Fundamental -
Dividend Rating -
Return 12m vs S&P 500 -9.85%
Analyst Rating -

VXZ Dividends

Currently no dividends paid

VXZ Growth Ratios

Growth Correlation 3m -67.9%
Growth Correlation 12m 70.2%
Growth Correlation 5y -87.7%
CAGR 5y -21.28%
CAGR/Max DD 3y -0.35
CAGR/Mean DD 3y -0.40
Sharpe Ratio 12m 0.35
Alpha -9.06
Beta 0.737
Volatility 20.93%
Current Volume 29.8k
Average Volume 20d 7.1k
Stop Loss 54.2 (-3.1%)
Signal 1.08

What is the price of VXZ shares?

As of September 16, 2025, the stock is trading at USD 55.96 with a total of 29,802 shares traded.
Over the past week, the price has changed by -0.82%, over one month by -4.64%, over three months by -5.76% and over the past year by +7.18%.

Is iPath Series SP500 VIX a good stock to buy?

Neither. Based on ValueRay´s Analyses, iPath Series SP500 VIX is currently (September 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -23.68 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VXZ is around 42.94 USD . This means that VXZ is currently overvalued and has a potential downside of -23.27%.

Is VXZ a buy, sell or hold?

iPath Series SP500 VIX has no consensus analysts rating.

What are the forecasts/targets for the VXZ price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 48 -14.3%

Last update: 2025-09-06 04:51

VXZ Fundamental Data Overview

Market Cap USD = 36.9m (36.9m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 13.04
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 36.9m USD (36.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 36.9m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 36.9m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(36.9m)/V(0.0) * Re(8.73%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for VXZ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle